The public cord blood bank would enable us to collect cord blood from delivery and birthing centers, process these specimens, type their HLA signature and store them in ultra-low temperature conditions for use on prospective recipients. These recipients would have to be matched against their HLA signature with the stored stem cell concentrate.

Patients with a disease treatable by stem cell therapy would have to have their HLA type known and they approach us for treatment. Such patients would be matched against our library of samples to identify a suitable match which would then be issued at a nominal cost. The cost of therapy would however be separate and informed to the patient before embarking on the treatment.

One of the advantages of cord blood derived stem cell therapy is that the HLA match needs to be only a 4/6 match instead of the 6/6 match that is mandatory in a bone marrow transplant. Also, the chances of GVHD (Graft-versus-host-disease) are less likely compared to matched bnone marrow transplants.

The patient would agree to undergo the stem cell therapy and would sign all the necessary consent forms that are mandatory. If needed, the Institutional Committee for Stem Cell Research and therapy (IC-SCRT) would also clear such a therapy.

Philanthropists, donors and NGOs are urged to “adopt” batches of samples so that these samples could be tested, HLA typed, screened for genetic diseases and be issued to deserving patients.

Click here to send us a message for donation of samples(Link to donation of samples)

Click here to support the public bank (Link to donation of funds)

This way, the collection, storage and issue of stem cells obtained from the cord blood and cord tissue could be really taken forward to a logical end of making the novel therapy available to the masses.